CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Crispr Therapeutics Ag  (CRSP)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Crispr Therapeutics Ag's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

CRSP Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter



Y / Y Revenue Change - - - - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 49 # # # #
Seq. Revenue Change - - - - -
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2017 Gross Margin
Crispr Therapeutics Ag achieved Gross Profit of $3 millions compare to Gross Loss of $0.00 millions recorded in previous quarter. Revenue increased by 0 % Company achieved below average Gross Margin with 100 %.

Observing first quarter 2017 results within Biotechnology & Drugs industry 5 other companies have achieved higher Gross Margin. While Gross Margin overall ranking has deteriorated compare to previous quarter from to 49.
Learn about Gross Margin
CRSP's Gross Margin first quarter 2017 Company Ranking
Within: No.
Industry # 6
Sector # 16
S&P 500 # 49

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Crispr Therapeutics Ag's (Mar 31 2017) Gross Profit $ 3 CRSP's Income Statement
Crispr Therapeutics Ag's Gross Profit $ 0 Quarterly CRSP's Growth
CRSP's Profits by Division See CRSP's Profits by Segment

Other Gross Margin Profitability Ratios
CRSP's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
CRSP's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for CRSP's Competitors
Gross Margin Profit Margin for Crispr Therapeutics Ag's Suppliers
Gross Margin Profit Margin for CRSP's Customers

You may also want to know
CRSP's Annual Growth Rates CRSP's Profitability Ratios CRSP's Asset Turnover Ratio CRSP's Dividend Growth
CRSP's Roe CRSP's Valuation Ratios CRSP's Financial Strength Ratios CRSP's Gross Profit Growth
CRSP's Roa CRSP's Inventory Turnover Ratio CRSP's Growth Rates CRSP's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Biotechnology & Drugs Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Sangui Biotech International Inc  217.68 %$ 0.025 $ 0.012 
Juno Therapeutics, Inc.  100.00 %$ 19.327 $ 19.327 
Idera Pharmaceuticals, Inc.  100.00 %$ 0.378 $ 0.378 
Innovus Pharmaceuticals, Inc.  100.00 %$ 2.177 $ 2.177 
Kite Pharma, Inc.  100.00 %$ 9.836 $ 9.836 
Mymetics Corp  100.00 %$ 0.383 $ 0.383 
Momenta Pharmaceuticals Inc  100.00 %$ 26.614 $ 26.614 
Fate Therapeutics Inc  100.00 %$ 1.027 $ 1.027 
Dimension Therapeutics, Inc.  100.00 %$ 3.618 $ 3.618 
Curis Inc  100.00 %$ 2.131 $ 2.131 
Cocrystal Pharma, Inc.  100.00 %$ 0.002 $ 0.002 
Crispr Therapeutics Ag  100.00 %$ 2.703 $ 2.703 
Cytomx Therapeutics, Inc.  100.00 %$ 11.653 $ 11.653 
Myokardia Inc  100.00 %$ 5.625 $ 5.625 
Neuralstem, Inc.  100.00 %$ 0.003 $ 0.003 
Enumeral Biomedical Holdings, Inc.  100.00 %$ 0.029 $ 0.029 
Nantkwest, Inc.  100.00 %$ 0.011 $ 0.011 
Regenerx Biopharmaceuticals Inc  100.00 %$ 0.013 $ 0.013 
Proteostasis Therapeutics, Inc.  100.00 %$ 1.021 $ 1.021 
Repros Therapeutics Inc.  100.00 %$ 0.007 $ 0.007 
Sangamo Therapeutics, Inc  100.00 %$ 3.425 $ 3.425 
Tracon Pharmaceuticals, Inc.  100.00 %$ 0.626 $ 0.626 
Syndax Pharmaceuticals Inc  100.00 %$ 0.305 $ 0.305 
Proteo Inc  100.00 %$ 0.038 $ 0.038 
Tg Therapeutics, Inc.  100.00 %$ 0.038 $ 0.038 
Intellia Therapeutics, Inc.  100.00 %$ 6.215 $ 6.215 
Cannabics Pharmaceuticals Inc.  100.00 %$ 0.001 $ 0.001 
Novavax Inc  100.00 %$ 5.680 $ 5.680 
Spark Therapeutics, Inc.  100.00 %$ 1.274 $ 1.274 
Pulse Biosciences, Inc.  100.00 %$ 0.039 $ 0.039 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com